The Alabama Care Plan: Assessing the Impact of Regional Care Organizations on Diabetes Outcomes in a Sample of Alabama Medicaid Recipients
阿拉巴马州护理计划:评估区域护理组织对阿拉巴马州医疗补助接受者样本中糖尿病结果的影响
基本信息
- 批准号:9211324
- 负责人:
- 金额:$ 50.23万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-03-01 至 2021-02-28
- 项目状态:已结题
- 来源:
- 关键词:Accident and Emergency departmentAcuteAddressAlabamaBehavior TherapyBenchmarkingBlindnessCardiovascular systemCaringChargeChronicChronic DiseaseCitiesCommunity Health AidesComplications of Diabetes MellitusCountryDataData AnalysesDiabetes MellitusDiabetes preventionDiagnosisDimensionsDirect CostsDisease ManagementEffectivenessEligibility DeterminationEmergency department visitEnrollmentEpidemicEvaluationEventFee-for-Service PlansGlycosylated hemoglobin AGuidelinesHealthHealth Care CostsHealth PersonnelHealth systemHealthcareHome environmentHospitalizationImpact evaluationIndividualInstitutesInterruptionInterviewKidney FailureKnowledgeLeadLower ExtremityManaged CareMeasuresMedicaidModelingNon-Insulin-Dependent Diabetes MellitusOphthalmic examination and evaluationOrganizational ModelsOutcomePatientsPharmacistsPharmacological TreatmentPhase TransitionPoliciesPopulationPreparationPrevalencePreventionPrimary Care PhysicianPrimary Health CareQualitative MethodsResearchResearch PersonnelRiskSamplingSavingsSelf CareSelf ManagementSeriesServicesSocial WorkersStructureSurveysTeam NursingTelephoneTimeTime Series AnalysisUnited StatesUnited States Centers for Medicare and Medicaid ServicesWorkbasebeneficiarycostcost effectivenessdiabetes managementdisorder preventionexperienceglycemic controlhealth care deliveryhealth care service utilizationimprovedlimb amputationmortalitymultidisciplinarynovel strategiespaymentpolicy implicationpopulation healthprogramspublic health relevancerisk sharingsatisfactionsecondary outcomestem
项目摘要
DESCRIPTION (provided by applicant):Despite advances in the scientific knowledge related to diabetes prevention and management, diabetes prevalence, complications, and costs continues to rise. A majority of the dollars that go towards diabetes care are spent on Emergency Department visits, hospitalizations, and the management of diabetes complications. Changing the trajectory of the diabetes epidemic in the United States may require a fundamentally new approach to chronic disease management and reimbursement that emphasizes disease prevention and management. Accountable Care Organizations (ACOs) could be such an approach. Under this model, an organization is charged with the care of a population, receives a capitated payment and may be eligible for either a share of any savings achieved and/or at risk for a portion of any spending over the set target. As such, ACOs have been proposed as a means to simultaneously improve population health and reduce health care costs. The Alabama Medicaid program is undergoing a major transformation from a traditional fee for service model to the establishment of ACOs (referred to in Alabama as RCOs or Regional Care Organizations). The Alabama Care Plan, one of 6 probationary RCOs, will assume care for over 70,000 Medicaid recipients in Region B, 11% of whom have diabetes. In April 2015, VIVA Health, a local managed care organization and the lead entity in the Alabama Care Plan, began creating care coordination teams that will work with individuals' current health care providers to comprise a larger "health home." This phased transition provides a unique opportunity for us to assess the impact of policy change related to reimbursement and the delivery of health care as it relates to diabetes. With this proposal, investigators will conduct a
rigorous evaluation of the impact of this transition on outcomes in three dimensions: health of a population, experience of care, and per capita cost. The specific aims are: 1. To examine changes in diabetes related population health measures, including glycemic control (HbA1c) and indicators of diabetes care (quarterly HbA1c, annual eye exam); 2. To examine patient experience of care using a telephone-administered survey and qualitative interviews with a subset of individuals with type 2 diabetes enrolled in the Health Home; and 3.To examine changes in health care utilization and overall cost effectiveness of the newly implemented RCO and Health Home compared to diabetes care before RCO implementation. Using Medicaid data beginning in 2010 through 2019, investigators will conduct interrupted time series analyses of data from enrollees within Region B and difference-in- differences analyses to compare changes over time in Region B with changes over time in 3 southern, non- ACO states. The multidisciplinary team of investigators has expertise in diabetes research, use of CMS data, survey administration and qualitative methods. Alabama has the highest rate of diabetes in the United States. As such, this study could have important local and national policy implications for new approaches to diabetes management.
描述(由申请人提供):尽管与糖尿病预防和管理相关的科学知识取得了进展,但糖尿病患病率、并发症和费用仍在持续上升。用于糖尿病护理的大部分美元用于急诊科就诊,住院治疗和糖尿病并发症的管理。改变美国糖尿病流行的轨迹可能需要一种全新的慢性病管理和报销方法,强调疾病预防和管理。问责护理组织(ACO)可能是这样一种方法。根据这一模式,一个组织负责照顾一个人口,收到一笔资本付款,并可能有资格获得所实现的任何节余的一部分和(或)有资格承担超过既定目标的任何支出的一部分的风险。因此,ACO已被提议作为同时改善人口健康和降低医疗保健成本的手段。亚拉巴马医疗补助计划正在经历一个重大转变,从传统的服务模式收费到建立ACO(在亚拉巴马称为RCO或区域护理组织)。亚拉巴马护理计划是6个试用RCO之一,将为B区的7万多名医疗补助接受者提供护理,其中11%患有糖尿病。2015年4月,VIVA Health,一家当地的管理式医疗机构,也是亚拉巴马医疗计划的牵头实体,开始创建医疗协调团队,与个人目前的医疗保健提供者合作,组成一个更大的“健康之家”。“这一分阶段的过渡为我们提供了一个独特的机会,以评估与糖尿病有关的报销和医疗保健提供政策变化的影响。根据这项建议,调查人员将进行一项
严格评估这一转变对三个方面结果的影响:人口健康、护理经验和人均成本。具体目标是:1.检查糖尿病相关人群健康指标的变化,包括血糖控制(HbA 1c)和糖尿病护理指标(季度HbA 1c,年度眼科检查); 2.使用电话管理调查和定性访谈对健康之家登记的2型糖尿病患者子集的护理经验进行检查; 3.与RCO实施前的糖尿病护理相比,检查新实施的RCO和健康之家的医疗保健利用率和总体成本效益的变化。使用2010年至2019年开始的Medicaid数据,研究者将对区域B内入组者的数据进行中断时间序列分析和差异中差异分析,以比较区域B随时间的变化与3个南部非ACO州随时间的变化。多学科的研究人员团队在糖尿病研究,CMS数据的使用,调查管理和定性方法方面具有专业知识。亚拉巴马是美国糖尿病发病率最高的地区。因此,这项研究可能对糖尿病管理的新方法具有重要的地方和国家政策意义。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Andrea L Cherrington其他文献
Andrea L Cherrington的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Andrea L Cherrington', 18)}}的其他基金
The Alabama Cardiovascular Cooperative: Supporting Cardiovascular Risk Reduction in Primary Care
阿拉巴马州心血管合作社:支持初级保健中降低心血管风险
- 批准号:
10542719 - 财政年份:2021
- 资助金额:
$ 50.23万 - 项目类别:
The Alabama Cardiovascular Cooperative: Supporting Cardiovascular Risk Reduction in Primary Care
阿拉巴马州心血管合作社:支持初级保健中降低心血管风险
- 批准号:
10323063 - 财政年份:2021
- 资助金额:
$ 50.23万 - 项目类别:
Collaboration to Improve Blood Pressure in the US Black Belt- Addressing the Triple Threat
合作改善美国黑带血压——应对三重威胁
- 批准号:
10191671 - 财政年份:2020
- 资助金额:
$ 50.23万 - 项目类别:
The Alabama Care Plan: Assessing the Impact of Regional Care Organizations on Diabetes Outcomes in a Sample of Alabama Medicaid Recipients
阿拉巴马州护理计划:评估区域护理组织对阿拉巴马州医疗补助接受者样本中糖尿病结果的影响
- 批准号:
9889955 - 财政年份:2016
- 资助金额:
$ 50.23万 - 项目类别:
The Alabama Care Plan: Assessing the Impact of Regional Care Organizations on Diabetes Outcomes in a Sample of Alabama Medicaid Recipients
阿拉巴马州护理计划:评估区域护理组织对阿拉巴马州医疗补助接受者样本中糖尿病结果的影响
- 批准号:
9102469 - 财政年份:2016
- 资助金额:
$ 50.23万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 50.23万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 50.23万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 50.23万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 50.23万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 50.23万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 50.23万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 50.23万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 50.23万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 50.23万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 50.23万 - 项目类别:
Operating Grants














{{item.name}}会员




